In less than a decade, Morgantown, W. Va.-based WVU Medicine’s Heart and Vascular Institute has grown from 25 providers to more than 200, expanding from a $225 million regional program to a $2 billion healthcare destination, delivering nearly 450,000 patient visits in 2024. In the past year, the Heart and Vascular Institute team performed the world’s first robotic transcatheter aortic valve replacement explant and aortic valve replacement, and the world’s first combined robotic aortic valve replacement and coronary artery bypass operation.
Vinay Badhwar, MD, executive chair of the institute, attributes the growth and success to the forward thinking mindset of three leaders — Albert Wright, WVU Medicine’s president and CEO; Clay Marsh, MD, chancellor and executive dean of West Virginia U